Product Code: ETC13276314 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Gastroparesis Market was valued at USD 2.3 Billion in 2024 and is expected to reach USD 3.4 Billion by 2031, growing at a compound annual growth rate of 5.80% during the forecast period (2025-2031).
The global gastroparesis market is witnessing steady growth, fueled by factors such as the rising prevalence of gastroparesis, increasing awareness about the disease, and advancements in treatment options. Gastroparesis is a chronic condition characterized by delayed gastric emptying, leading to symptoms such as nausea, vomiting, abdominal pain, and early satiety. The market is driven by the development of novel therapies, including prokinetic agents, gastric electrical stimulation, and botulinum toxin injections. Additionally, a growing geriatric population and the high incidence of diabetes, which is a major risk factor for gastroparesis, are contributing to market growth. Key players in the global gastroparesis market are focusing on strategic collaborations, product launches, and acquisitions to expand their product portfolios and strengthen their market presence.
The Global Gastroparesis Market is witnessing several key trends and opportunities. The increasing prevalence of gastroparesis, driven by factors such as a rise in diabetes cases and changing dietary habits, is a significant trend driving market growth. Technological advancements in diagnostics and treatment options, such as novel drug therapies and minimally invasive surgical procedures, are also contributing to the market expansion. Additionally, the growing focus on patient-centric care and personalized treatment approaches present opportunities for market players to develop innovative solutions tailored to individual patient needs. Furthermore, strategic collaborations between pharmaceutical companies and research institutions for drug development and clinical trials are expected to further propel market growth in the coming years.
The Global Gastroparesis Market faces several challenges, including limited awareness about the condition among both healthcare providers and patients, leading to delayed diagnosis and treatment. Additionally, the lack of specific diagnostic tests for gastroparesis can result in misdiagnosis or underdiagnosis. Treatment options for gastroparesis are also limited, with currently available medications providing only symptomatic relief for some patients and not addressing the underlying cause. Furthermore, the high cost of existing treatment options and the potential for side effects can pose financial and health risks for patients. Research and development efforts are needed to improve diagnostic tools, develop more effective treatments, and increase awareness to address these challenges in the Global Gastroparesis Market.
The global gastroparesis market is primarily driven by the increasing prevalence of diabetes, as diabetic patients are at a higher risk of developing gastroparesis. Additionally, the growing aging population worldwide is contributing to the rising number of gastroparesis cases, as the condition is more common in older individuals. Technological advancements in diagnostic procedures and treatment options are also driving market growth by improving early detection and management of gastroparesis. Furthermore, the rising awareness about gastrointestinal disorders and their impact on overall health is increasing the demand for effective gastroparesis treatments. Overall, the market is expected to continue expanding due to these key drivers shaping the healthcare landscape.
Government policies related to the Global Gastroparesis Market focus on increasing awareness about the condition, improving access to healthcare services, and promoting research and development for innovative treatments. The government aims to enhance early diagnosis and treatment options for patients with gastroparesis through initiatives such as funding research studies, providing grants to support clinical trials, and collaborating with healthcare providers to develop guidelines for the management of the disease. Additionally, regulatory bodies work towards ensuring the safety and efficacy of medications and medical devices used in the treatment of gastroparesis, while also monitoring healthcare practices to prevent potential issues such as misdiagnosis or inappropriate treatments. Overall, government policies aim to address the unmet needs of patients with gastroparesis and improve their quality of life through comprehensive and effective strategies.
The Global Gastroparesis Market is expected to experience steady growth in the coming years due to factors such as increasing prevalence of gastroparesis, advancements in diagnostic technologies, and rising awareness among healthcare professionals and patients. The market is likely to be driven by the development of novel treatment options, including drug therapies and medical devices, as well as the growing focus on personalized medicine. Furthermore, the aging population and the rising incidence of risk factors such as diabetes and obesity are anticipated to contribute to the expanding market size. However, challenges such as high treatment costs and limited accessibility to healthcare services in some regions may hinder market growth. Overall, the Global Gastroparesis Market is poised for growth, offering opportunities for pharmaceutical companies, medical device manufacturers, and healthcare providers to address unmet needs in this space.
The global gastroparesis market exhibits variations across regions. In Asia, the market is driven by the rising prevalence of diabetes and increasing healthcare expenditure. North America leads the market due to advanced healthcare infrastructure, higher awareness levels, and a significant patient population. Europe follows closely with a growing geriatric population and increasing research and development activities. The Middle East and Africa region is witnessing a gradual rise in gastroparesis cases due to changing lifestyles and dietary habits. In Latin America, the market is expanding as healthcare facilities improve and awareness about gastrointestinal disorders increases. Overall, the global gastroparesis market is projected to grow steadily across all regions, with varying degrees of market penetration and growth opportunities.
Global Gastroparesis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Gastroparesis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Gastroparesis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Gastroparesis Market - Industry Life Cycle |
3.4 Global Gastroparesis Market - Porter's Five Forces |
3.5 Global Gastroparesis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Gastroparesis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Gastroparesis Market Revenues & Volume Share, By Drug Class Type, 2021 & 2031F |
3.8 Global Gastroparesis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Gastroparesis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Gastroparesis Market Trends |
6 Global Gastroparesis Market, 2021 - 2031 |
6.1 Global Gastroparesis Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Gastroparesis Market, Revenues & Volume, By Idiopathic, 2021 - 2031 |
6.1.3 Global Gastroparesis Market, Revenues & Volume, By Diabetic, 2021 - 2031 |
6.1.4 Global Gastroparesis Market, Revenues & Volume, By Post-Surgical, 2021 - 2031 |
6.1.5 Global Gastroparesis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Gastroparesis Market, Revenues & Volume, By Drug Class Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Gastroparesis Market, Revenues & Volume, By Prokinetic Agents, 2021 - 2031 |
6.2.3 Global Gastroparesis Market, Revenues & Volume, By Antiemetic Agents, 2021 - 2031 |
6.2.4 Global Gastroparesis Market, Revenues & Volume, By Botulinum Toxin Injection, 2021 - 2031 |
6.3 Global Gastroparesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Gastroparesis Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.3.3 Global Gastroparesis Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.3.4 Global Gastroparesis Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Gastroparesis Market, Overview & Analysis |
7.1 North America Gastroparesis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Gastroparesis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Gastroparesis Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Gastroparesis Market, Revenues & Volume, By Drug Class Type, 2021 - 2031 |
7.5 North America Gastroparesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Gastroparesis Market, Overview & Analysis |
8.1 Latin America (LATAM) Gastroparesis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Gastroparesis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Gastroparesis Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Gastroparesis Market, Revenues & Volume, By Drug Class Type, 2021 - 2031 |
8.5 Latin America (LATAM) Gastroparesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Gastroparesis Market, Overview & Analysis |
9.1 Asia Gastroparesis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Gastroparesis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Gastroparesis Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Gastroparesis Market, Revenues & Volume, By Drug Class Type, 2021 - 2031 |
9.5 Asia Gastroparesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Gastroparesis Market, Overview & Analysis |
10.1 Africa Gastroparesis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Gastroparesis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Gastroparesis Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Gastroparesis Market, Revenues & Volume, By Drug Class Type, 2021 - 2031 |
10.5 Africa Gastroparesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Gastroparesis Market, Overview & Analysis |
11.1 Europe Gastroparesis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Gastroparesis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Gastroparesis Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Gastroparesis Market, Revenues & Volume, By Drug Class Type, 2021 - 2031 |
11.5 Europe Gastroparesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Gastroparesis Market, Overview & Analysis |
12.1 Middle East Gastroparesis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Gastroparesis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Gastroparesis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Gastroparesis Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Gastroparesis Market, Revenues & Volume, By Drug Class Type, 2021 - 2031 |
12.5 Middle East Gastroparesis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Gastroparesis Market Key Performance Indicators |
14 Global Gastroparesis Market - Export/Import By Countries Assessment |
15 Global Gastroparesis Market - Opportunity Assessment |
15.1 Global Gastroparesis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Gastroparesis Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Gastroparesis Market Opportunity Assessment, By Drug Class Type, 2021 & 2031F |
15.4 Global Gastroparesis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Gastroparesis Market - Competitive Landscape |
16.1 Global Gastroparesis Market Revenue Share, By Companies, 2024 |
16.2 Global Gastroparesis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |